BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 4958797)

  • 1. Comparison of single and divided daily dosages of isoniazid and PAS in the treatment of pulmonary tuberculosis. XV. A report of the Veterans Administration-Armed Forces Cooperative. Study on the chemotherapy of tuberculosis.
    Reisner D
    Am Rev Respir Dis; 1966 Dec; 94(6):849-57. PubMed ID: 4958797
    [No Abstract]   [Full Text] [Related]  

  • 2. Capreomycin compared with streptomycin in original treatment of pulmonary tuberculosis. XVI. A report of the Veterans Administration-Armed Forces Cooperative. Study on the Chemotherapy of Tuberculosis.
    Schwartz W
    Am Rev Respir Dis; 1966 Dec; 94(6):858-64. PubMed ID: 4958888
    [No Abstract]   [Full Text] [Related]  

  • 3. Rifampicin plus isoniazid, rifampicin plus PAS, and isoniazid plus PAS in the initial treatment of pulmonary tuberculosis. A controlled multicenter clinical trial.
    Tousek J; Votruba R
    Chemotherapy; 1974; 20(3):183-200. PubMed ID: 4605071
    [No Abstract]   [Full Text] [Related]  

  • 4. [Factors relating to the incidence of drug resistance for anti-tuberculosis drugs during chemotherapy. Relationship between the incidence of drug resistance and the course of original treatment].
    Yamamoto M; Nakamura H
    Kekkaku; 1971 Jun; 46(6):191-5. PubMed ID: 4997826
    [No Abstract]   [Full Text] [Related]  

  • 5. Controlled comparison of oral twice-weekly and oral daily isoniazid plus PAS in newly diagnosed pulmonary tuberculosis.
    Br Med J; 1973 Apr; 2(5857):7-11. PubMed ID: 4633061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethambutol in the initial treatment of pulmonary tuberculosis. U.S. Public Health Service tuberculosis therapy trials.
    Doster B; Murray FJ; Newman R; Woolpert SF
    Am Rev Respir Dis; 1973 Feb; 107(2):177-90. PubMed ID: 4567069
    [No Abstract]   [Full Text] [Related]  

  • 7. A controlled clinical trial of the drug treatment of new cases of pulmonary tuberculosis.
    Böszörményi M; Schweiger O
    Scand J Respir Dis Suppl; 1968; 65():189-93. PubMed ID: 4978460
    [No Abstract]   [Full Text] [Related]  

  • 8. Failure of isoniazid prophylaxis after exposure to isoniazid-resistant tuberculosis.
    Fairshter RD; Randazzo GP; Garlin J; Wilson AF
    Am Rev Respir Dis; 1975 Jul; 112(1):37-42. PubMed ID: 807140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two regimens of simplified two-stage chemotherapy in previously untreated pulmonary tuberculosis.
    Bethlem N; Gerhardt FO G; Magarăo S
    Tubercle; 1973 Sep; 54(3):180-4. PubMed ID: 4204111
    [No Abstract]   [Full Text] [Related]  

  • 10. Ethambutol treatment of tuberculosis in a controlled trial.
    Segarra FO; Lorian V; Sherman DS
    Scand J Respir Dis; 1968; 49(3):202-6. PubMed ID: 4980226
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethambutol-isoniazid versus PAS-isoniazid in original treatment of pulmonary tuberculosis.
    Bobrowitz ID; Robins DE
    Am Rev Respir Dis; 1967 Sep; 96(3):428-38. PubMed ID: 6039097
    [No Abstract]   [Full Text] [Related]  

  • 12. [Proceedings: Results of a controlled trial of intermittent ambulatory therapy of infectious pulmonary tuberculosis with comparison of various maintenance regimens].
    Ganguin HG; Cramer G; Götz J; Holzhauer H; Niegsch G; Sieler H; Velten G; Völker L
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):107-15. PubMed ID: 4203235
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative trial of thiacetazone with isoniazid and paraaminosalicyclic acid (PAS) with isoniazid in the treatment of pulmonary tuberculosis in Nigerians.
    Onadeko BO; Sofowora EO
    J Trop Med Hyg; 1975 Sep; 78(9):201-5. PubMed ID: 57244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative tests with old tuberculin in sanatorium practice.
    Woodruff CE; Chapman PT; Howard WL; Klopfenstein MD; Steininger WJ
    Am Rev Respir Dis; 1968 Aug; 98(2):270-6. PubMed ID: 4970048
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 2. A controlled trial on the clinical effects of chemotherapy with Rifampicin-INH-PAS and SM-INH-PAS for treatment of original cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1970 Aug; 45(8):257-62. PubMed ID: 4918166
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison between SM daily and twice weekly treatment in the regimen of SM, INH and PAS--particularly considering the degree of drug resistance-- (report 1) (author's transl)].
    Baba H; Azuma Y
    Kekkaku; 1975 Jul; 50(7):191-7. PubMed ID: 810615
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of three regimens, INH-SM-PAS, INH-SM-RFP and INH-PAS-RFP, in the original treatment cases of pulmonary tuberculosis. Report of the 13th series study (original treatment study)].
    Kekkaku; 1973 Jun; 48(6):235-45. PubMed ID: 4581528
    [No Abstract]   [Full Text] [Related]  

  • 18. A controlled comparison of two fully supervised once-weekly regimens in the treatment of newly diagnosed pulmonary tuberculosis.
    Tubercle; 1973 Mar; 54(1):23-45. PubMed ID: 4204397
    [No Abstract]   [Full Text] [Related]  

  • 19. A four-year follow-up of patients with quiescent pulmonary tuberculosis at the end of a year of chemotherapy with twice-weekly isoniazid plus streptomycin or daily isoniazid plus pas.
    Ramakrishnan CV; Devadatta S; Evans C; Fox W; Menon NK; Nazareth O; Radhakrishna S; Sambamoorthy S; Stott H; Tripathy SP; Velu S
    Tubercle; 1969 Jun; 50(2):115-24. PubMed ID: 4892322
    [No Abstract]   [Full Text] [Related]  

  • 20. Short-course chemotherapy for pulmonary tuberculosis.
    Fox W; Mitchison DA
    Am Rev Respir Dis; 1975 Mar; 111(3):325-53. PubMed ID: 47233
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.